How should I evaluate and manage a male patient with intermittent erectile dysfunction who no longer reports morning erections, considering possible vascular, hormonal, migraine, and gastrointestinal causes?

Evaluation and Management of Erectile Dysfunction Without Morning Erections

The absence of morning erections in a male patient with intermittent erectile dysfunction suggests organic (likely vascular, hormonal, or neurologic) rather than purely psychogenic ED, and mandates a comprehensive workup including morning serum total testosterone, cardiovascular risk assessment, and consideration of PDE5 inhibitor therapy. 1

Clinical Significance of Absent Morning Erections

The absence of nocturnal and morning erections is a critical diagnostic finding. According to the 2018 AUA guidelines, the presence of morning erections suggests (but does not confirm) a psychogenic component to ED, while their absence points toward organic pathology requiring more thorough investigation 1.

Mandatory Initial Workup

History Components

Focus your history on:

• Onset and progression of symptoms (gradual onset suggests organic causes)
• Situational factors: Does ED occur with all partners or only specific situations?
• Presence of masturbatory erections (if present, suggests psychogenic component)
• Cardiovascular risk factors: smoking, diabetes, hypertension, dyslipidemia, family history of vascular disease
• Medications that may contribute to ED
• Comorbid conditions: particularly diabetes, hypertension, metabolic syndrome
• Psychosocial factors: depression, anxiety, relationship conflicts 1

Physical Examination

Perform:

• Vital signs: pulse and blood pressure
• Genital examination: assess for penile skin lesions, urethral meatus placement, occult deformities or plaques (Peyronie's disease)
• Palpate penis from pubic bone to coronal sulcus while stretched 1

Laboratory Testing

Mandatory tests per AUA guidelines:

• Morning serum total testosterone (drawn before 10 AM) - this is a moderate recommendation with Grade C evidence 1
• Fasting glucose or HbA1c - to screen for diabetes
• Lipid profile - cardiovascular risk assessment 2

Testosterone deficiency is defined as total testosterone <300 ng/dL with presence of symptoms and signs 1

Critical Cardiovascular Connection

ED is a risk marker for underlying cardiovascular disease and should trigger cardiovascular risk assessment. The presence of ED is as strong a predictor of future cardiac events as cigarette smoking or family history of myocardial infarction 1. This is a clinical principle in the AUA guidelines, meaning you must counsel the patient about this increased cardiovascular risk and coordinate with their primary care provider for appropriate cardiovascular evaluation 1.

Addressing Migraine and Gastrointestinal Concerns

Migraine Connection

Recent evidence demonstrates that chronic migraine is independently associated with erectile dysfunction. A 2022 study found significantly lower IIEF-5 scores in chronic migraine patients compared to controls, with a negative correlation between migraine pain severity (VAS scores) and erectile function 3. A 2025 meta-analysis confirmed that patients with migraine have more than 6 times higher likelihood of sexual dysfunction (OR 6.13) 4.

If your patient has chronic migraine, this is a contributing factor to ED that requires concurrent management 3, 5. The association is particularly strong in patients aged 40-60 years with comorbid hypertension, diabetes, or cardiovascular disease 5.

Gastrointestinal Considerations

While the provided evidence doesn't directly address GI causes of ED, metabolic syndrome (which often includes GI manifestations) is strongly associated with ED 6. Screen for metabolic syndrome components.

Treatment Algorithm

First-Line Therapy

Initiate treatment with an FDA-approved PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) unless contraindicated - this is a strong recommendation with Grade B evidence 1, 7.

Key prescribing principles:

• Provide explicit instructions on proper use to maximize efficacy (strong recommendation, Grade C) 1
• Titrate the dose to optimal efficacy (strong recommendation, Grade B) 1
• Base the choice of specific PDE5i on patient preference, cost, ease of use, and adverse effect profile 7
• All four agents have similar efficacy in the general ED population 1

Common pitfalls to avoid:

• Patients often don't take PDE5 inhibitors correctly (timing, food interactions, need for sexual stimulation)
• Inadequate dose titration leads to perceived treatment failure
• Not addressing cardiovascular contraindications (nitrate use is absolute contraindication)

Addressing Organic Causes

If testosterone is <300 ng/dL with symptoms:

• Consider testosterone replacement therapy per AUA testosterone deficiency guidelines 1

If cardiovascular risk factors identified:

• Aggressive risk factor modification: smoking cessation, diabetes control, hypertension management, lipid optimization
• These interventions may improve ED spontaneously 6

If migraine is present:

• Optimize migraine management as this may improve erectile function 3, 4

Psychological Component

Consider referral to mental health professional to:

• Reduce performance anxiety
• Improve communication about sexual concerns
• Integrate ED treatments into sexual relationship
• This is a moderate recommendation with Grade C evidence 1

This is particularly important even with organic ED, as psychological factors often become secondary contributors.

Specialized Testing

For patients with complex presentations or treatment failures, consider:

• Nocturnal penile tumescence and rigidity testing (can definitively assess organic vs. psychogenic ED)
• Intracavernosal injection with penile duplex ultrasound (evaluates vascular response)
• These are expert opinion recommendations 1

Key Clinical Pearls

• Absent morning erections = organic pathology until proven otherwise
• ED is a cardiovascular warning sign - don't miss the opportunity for cardiovascular risk reduction
• Morning testosterone testing is mandatory - not optional
• PDE5 inhibitors work less effectively in patients with diabetes and post-prostatectomy, requiring higher doses or alternative approaches 1
• Chronic migraine significantly impairs erectile function and should be addressed concurrently 3, 4, 5